Table 1 |
|
|
Characteristics of diabetic patients registered in clinics (March 2002–June 2008) |
|
|
Characteristic |
Value |
|
|
|
|
Total no. of diabetic patients registered |
4,404 |
|
Type of diabetes, n (%): |
|
|
Type 1 |
54 (1.2%) |
|
Type 2 |
4,350 (98.8%) |
|
Age in years, median (IQR) |
53 (46 to 60) |
|
Age group in years, n (%): |
|
|
≥39 |
438 (10.0%) |
|
40 to 49 |
1,168 (26.5%) |
|
50 to 59 |
1,540 (35.0%) |
|
≥60 |
1,258 (28.6%) |
|
Women, n(%) |
2,905 (66.0%) |
|
Origin of patients*, n (%): |
|
|
District of clinic |
1,724 (41.2%) |
|
Other districts of province |
1,550 (37.0%) |
|
Outside province |
912 (21.8%) |
|
Random plasma glucose on admission, median (IQR) |
272 (196 to 376) |
|
Random plasma glucose <180 mg/dl, n (%) |
797/4,095 (19.5%) |
|
HbA1c on admission %, median (IQR) (n = 950) |
11.5 (9.1 to 13.5) |
|
HbA1c <7%, n (%) |
59/950 (6.2%) |
|
Blood pressure on admission, n (%): |
|
|
Systolic ≥140 mm Hg |
1,555/3,840 (40.5%) |
|
Diastolic ≥90 mm Hg |
1,316/3,840 (34.3%) |
|
BMI on admission, kg/m2, median (IQR) (n = 4337): |
|
|
All patients |
23.5 (20.9 to 26) |
|
Men |
23 (20.1 to 26) |
|
Women |
23.7 (21.1 to 26.2) |
|
BMI ≥23 kg/m2, n (%) |
2,433/4,337 (56.1%) |
|
BMI ≥27.5 kg/m2, n (%) |
686/4,337 (15.8%) |
|
Treatment on last consultation, n (%): |
|
|
No antidiabetic drug |
91 (2.2%) |
|
Oral antidiabetic drug(s) alone |
3,911 (94.1%) |
|
Insulin alone |
115 (2.8%) |
|
Oral antidiabetic drug(s) plus insulin |
41 (1.0%) |
|
No data |
246 |
|
|
|
|
*Data on origin available only for patients admitted until February 2008. BMI = body mass index; HbA1c = glycosylated hemoglobin; IQR = interquartile range. |
|
|
Raguenaud et al. BMC Medicine 2009 7:33 doi:10.1186/1741-7015-7-33 |
|
